PMH66 QUALITY OF LIFE AND PATIENT-REPORTED OUTCOMES- COMPARISONS OF INDIVIDUALS WITH SCHIZOPHRENIA TREATED WITH ORAL AND LONG-ACTING INJECTABLE FORMULATIONS OF OLANZAPINE

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74785-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)74785-9/fulltext
Title : PMH66 QUALITY OF LIFE AND PATIENT-REPORTED OUTCOMES- COMPARISONS OF INDIVIDUALS WITH SCHIZOPHRENIA TREATED WITH ORAL AND LONG-ACTING INJECTABLE FORMULATIONS OF OLANZAPINE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74785-9&doi=10.1016/S1098-3015(10)74785-9
First page :
Section Title :
Open access? : No
Section Order : 710
Categories :
Tags :
Regions :
ViH Article Tags :